Transcriptome and proteome expressions involved in insulin resistance in muscle and activated T-lymphocytes of patients with type 2 diabetes.
about
Fat oxidation, fitness and skeletal muscle expression of oxidative/lipid metabolism genes in South Asians: implications for insulin resistance?The association of ENPP1 K121Q with diabetes incidence is abolished by lifestyle modification in the diabetes prevention programENPP1 affects insulin action and secretion: evidences from in vitro studies.Deficiency of the bone mineralization inhibitor NPP1 protects mice against obesity and diabetes.Pathobiochemical changes in diabetic skeletal muscle as revealed by mass-spectrometry-based proteomicsThe role of HSP70 on ENPP1 expression and insulin-receptor activation.Proteomics of Skeletal Muscle: Focus on Insulin Resistance and Exercise Biology.The role of vitamin D in skeletal and cardiac muscle functionProteomics of skeletal muscle differentiation, neuromuscular disorders and fiber aging.Effects of insulin on the skin: possible healing benefits for diabetic foot ulcers.Assessment of human lymphocyte proliferation associated with metabolic syndrome.Association Between VDR FokI Polymorphism and Intervertebral Disk Degeneration.A High Frequency of Peripheral Blood IL-22(+) CD4(+) T Cells in Patients With New Onset Type 2 Diabetes Mellitus.Multiple functions of insulin-degrading enzyme: a metabolic crosslight?Advanced glycation end products-induced insulin resistance involves repression of skeletal muscle GLUT4 expression.Human αβ and γδ T Cells in Skin Immunity and Disease.Interactions Between the Neuroendocrine System and T Lymphocytes in Diabetes.Gender-effect on the contractile properties of skeletal muscle in streptozotocin-induced diabetic rats.Proteasome inhibition in skeletal muscle cells unmasks metabolic derangements in type 2 diabetes
P2860
Q28744500-7CC62C5F-D6D9-4845-A564-60ECE7C8FEA4Q30486119-0C240737-57FC-4B98-A4CB-DAC5B5DDD4FAQ33900871-4503CB71-7B38-45C5-A62A-5159D4C2AE8BQ34637356-1C751BEA-B43D-49A9-AE1B-827F96FE434CQ35864829-3911112B-0EFF-46EE-9116-9F6F7C4C2245Q37140562-57144B10-2E31-4C53-9418-5032D7790FC8Q37566439-68314F7E-FB11-43D4-92E1-685DE90132D4Q37715719-BF015847-DA50-42C0-9F85-0BB8600E37BBQ37727204-8334011A-5F7B-4153-AC00-E1035754FE7BQ38961364-249D4E3C-312D-4CCA-B49A-89F4E436E8E0Q42161026-635A00B0-DDB7-4324-A0BE-14CC2C8C38E3Q42560808-E6B6A08E-939A-432F-855F-3F55B0539A61Q45221291-5598CDF1-3AAB-4448-AFB5-ABB9ADD8899FQ50932512-367CEFCF-2FD9-4EEF-970D-788A60221165Q54986288-7054B173-3BA6-4116-AFC8-24C29B500FE6Q55265385-3B05D29A-AD82-49F5-BB92-009E392DC117Q55337327-A22C3978-D41E-49E0-A75D-385EC65372BFQ55429869-D948A6F6-1793-46A0-B1D7-D37335E318CAQ58449790-129EAE7D-18F1-47FF-8BBB-C6693630EF97
P2860
Transcriptome and proteome expressions involved in insulin resistance in muscle and activated T-lymphocytes of patients with type 2 diabetes.
description
2007 nî lūn-bûn
@nan
2007 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Transcriptome and proteome exp ...... patients with type 2 diabetes.
@ast
Transcriptome and proteome exp ...... patients with type 2 diabetes.
@en
Transcriptome and proteome exp ...... patients with type 2 diabetes.
@nl
type
label
Transcriptome and proteome exp ...... patients with type 2 diabetes.
@ast
Transcriptome and proteome exp ...... patients with type 2 diabetes.
@en
Transcriptome and proteome exp ...... patients with type 2 diabetes.
@nl
prefLabel
Transcriptome and proteome exp ...... patients with type 2 diabetes.
@ast
Transcriptome and proteome exp ...... patients with type 2 diabetes.
@en
Transcriptome and proteome exp ...... patients with type 2 diabetes.
@nl
P2860
P921
P1476
Transcriptome and proteome exp ...... patients with type 2 diabetes.
@en
P2093
Frankie B Stentz
P2860
P304
P356
10.1016/S1672-0229(08)60009-1
P577
2007-12-01T00:00:00Z